comparemela.com

Latest Breaking News On - Heald wealth management - Page 29 : comparemela.com

Robert W Baird Trims Thermo Fisher Scientific (NYSE:TMO) Target Price to $664 00

Robert W Baird Trims Thermo Fisher Scientific (NYSE:TMO) Target Price to $664 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Wealth Alliance Advisory Group LLC Trims Stake in Gilead Sciences, Inc (NASDAQ:GILD)

Wealth Alliance Advisory Group LLC trimmed its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,423 shares of the biopharmaceutical company’s stock after selling 135 shares during […]

Gilead Sciences, Inc (NASDAQ:GILD) Shares Sold by Ieq Capital LLC

Ieq Capital LLC trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 57,974 shares of the biopharmaceutical company’s stock after selling 3,875 shares during the […]

Pacific Sage Partners LLC Decreases Stock Holdings in Thermo Fisher Scientific Inc (NYSE:TMO)

Pacific Sage Partners LLC decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 8.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 751 shares of the medical research company’s stock after selling 69 shares during the quarter. […]

AdvisorNet Financial Inc Purchases 92 Shares of Thermo Fisher Scientific Inc (NYSE:TMO)

AdvisorNet Financial Inc grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,134 shares of the medical research company’s stock after acquiring an additional 92 shares during the quarter. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.